|Title:||Nucleic acid ligand complexes|
|Abstract:||This invention discloses a method for preparing a therapeutic or diagnostic complex comprised of a nucleic acid ligand and a lipophilic compound or non-immunogenic, high molecular weight compound by identifying a nucleic acid ligand by SELEX methodology and associating the nucleic acid ligand with a lipophilic compound or a non-immunogenic, high molecular weight compound. The invention further discloses complexes comprising one or more nucleic acid ligands in association with a lipophilic compound or non-immunogenic, high molecular weight compound.|
|Inventor(s):||Gold; Larry (Boulder, CO), Schmidt; Paul G (Niwot, CO), Janjic; Nebojsa (Boulder, CO)|
|Assignee:||NeXstar Pharmaceuticals, Inc. (Boulder, CO)|
Patent Claim Types:|
see list of patent claims
Field: Organic fine chemistry
Back Citations: 23rd percentile
Forward Citations: 1st percentile
|Patent Number||Expiration Date|
|6,147,204||November 14, 2012|
|PCT Filed||May 02, 1996||PCT Application Number:||PCT/US96/06171|
|PCT Publication Date:||November 07, 1996||PCT Publication Number:||WO96/34876|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.